Original Source(s)
Related Content
Nasal obstruction may worsen OSA indicators
Increases in apnea-hypopnea events were greatest among patients with an elevated baseline index, while evidence supporting mouth taping remained preliminary.
September 11, 2026
-
4 min
Extended antiviral therapy may not improve long COVID
Nirmatrelvir–ritonavir for up to 25 days failed to improve cognitive, autonomic, or exercise symptoms compared with placebo in a phase 2 trial.
September 4, 2026
-
4 min
